featured
Impact of Low vs Negative ER/PR Status on Clinicopathologic Characteristics and Survival Outcomes in HER2-Negative Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
NPJ breast cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancer
NPJ Breast Cancer 2022 Jul 11;8(1)80, R Yoder, BF Kimler, JM Staley, K Schwensen, YY Wang, K Finke, A O'Dea, L Nye, M Elia, G Crane, R McKittrick, R Pluenneke, S Madhusudhana, L Beck, A Shrestha, L Corum, M Marsico, SR Stecklein, AK Godwin, QJ Khan, P SharmaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.